Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

SkinnyRx vs TeleCareSpot

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #49Desk pick
SkinnyRx

Both molecules by needle or by tablet, with the whole term ladder printed on the product page before any intake — and a headline rate that is the twelve-month rung, charged as one $2,388 payment on day one.

Marked down on: FDA issued Lean Rx, Inc. dba SkinnyRx a warning letter in February 2026; the letter is public in FDA's warning-letter database

FDAWarning letter issued to Lean Rx, Inc. dba SkinnyRx in February 2026. See the FDA warning-letter database.

vs
Dispatch #134
TeleCareSpot

TeleCareSpot is a telehealth weight-loss platform offering doctor-prescribed compounded GLP-1s with flat, all-inclusive monthly pricing: compounded semaglutide at $299/month and tirzepatide at $399/month…

Marked down on: The LegitScript seal ID this provider publishes, #45936855, does not resolve on LegitScript's own CDN — checked August 2026, alongside six seal IDs from other providers that returned normally in the same pass

SkinnyRx takes this head-to-head with the higher Desk Score, 78/100 (C+) against 71/100 (C) for TeleCareSpot. TeleCareSpot still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

SkinnyRx

78/100

C+

Overall

TeleCareSpot

71/100

C

Price transparency

64
46

State access

86
78

Molecule range

92
77

Onboarding speed

80
78

Support responsiveness

80
76

Licensing & trust

62
93

The spec sheet

FieldSkinnyRxTeleCareSpot
Semaglutide$349/mo month-to-month (compounded; the advertised rate is a 12-month prepay)$299/mo (all doses, plus a separate fee, compounded)
Tirzepatide$399/mo month-to-month (compounded; the advertised rate is a 12-month prepay)$399/mo
Coverage47 states + DC (not Alabama, Louisiana or Mississippi)48 states
Brand-nameCompounded onlyCompounded only
Oral optionYesYes
Best forReaders who want a tablet route on either molecule and can pay a year up front; anyone shopping month to month should compare $349 and $399, not the advertised $199 and $299.Readers who want flat-priced compounded semaglutide or tirzepatide with broad state coverage.
Desk Score78/100C+71/100C

The verdict

Desk pick — SkinnyRx

SkinnyRx takes this head-to-head with the higher Desk Score, 78/100 (C+) against 71/100 (C) for TeleCareSpot. TeleCareSpot still holds its ground where its strengths line up with yours.

Choose SkinnyRx if…

Readers who want a tablet route on either molecule and can pay a year up front; anyone shopping month to month should compare $349 and $399, not the advertised $199 and $299.

$349/mo month-to-month (compounded; the advertised rate is a 12-month prepay) sema · $399/mo month-to-month (compounded; the advertised rate is a 12-month prepay) tirz · 47 states + DC (not Alabama, Louisiana or Mississippi)

FDAWarning letter issued to Lean Rx, Inc. dba SkinnyRx in February 2026. See the FDA warning-letter database.

Choose TeleCareSpot if…

Readers who want flat-priced compounded semaglutide or tirzepatide with broad state coverage.

$299/mo (all doses, plus a separate fee, compounded) sema · $399/mo tirz · 48 states

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: SkinnyRx · TeleCareSpot.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.